NIH-funded research R01 grant

Investigating a key enzyme in blood vessel changes related to high blood pressure

Official title: Vascular Pyruvate Kinase M2 in Hypertension

Funded at Temple Univ of the Commonwealth · NIH-11050618 · Data updated 2026-11-12

This study is looking at how a special enzyme affects blood vessel changes in people with high blood pressure, with the hope of finding new treatments to help manage their condition better.

More Hypertension research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startDecember 15, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$732,119
NIH project number1R01HL174004-01A1
Project IDNIH-11050618 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with hypertension, particularly those who may not be adequately controlled on current therapies.

Less likely to help

Patients with normal blood pressure or those whose hypertension is well-managed with existing treatments may not benefit from this research.

What this research studies

This research focuses on understanding how a specific enzyme, pyruvate kinase M2, influences changes in blood vessels associated with hypertension. By examining the role of this enzyme in vascular smooth muscle cells, the study aims to uncover mechanisms that contribute to the remodeling of blood vessels in patients with high blood pressure. The ultimate goal is to identify potential new therapies that could be added to existing treatments for hypertension, improving patient outcomes. The research will involve both laboratory experiments and analysis of cellular responses to angiotensin II, a hormone that plays a significant role in regulating blood pressure.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options that better manage hypertension and reduce the risk of cardiovascular diseases.

How similar studies have gone: Previous research has shown promising results in understanding metabolic shifts in cardiovascular diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Eguchi, Satoru — Temple Univ of the Commonwealth
  • Study coordinator: Eguchi, Satoru

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.